ArticleOncoimmunology2015

Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy.

Jian Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.